Point of Care Testing

TrilliumBiO and T-NeuroDx Partner to Advance Blood-Based Diagnostics for Early Alzheimer’s Detection

Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease ...

Takeda Secures FDA 510(k) Clearance for HyHub™ and HyHub™ Duo Devices

New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy...